Search database
LIST OPTIONS
Filter
45
Filtered Results: 45
Text search: nanoparticles
Featured
Language
Document type
Guidelines
14
Studies & Reports
13
No document type
10
Manuals
4
Fact sheets
4
Countries / Regions
Syria
3
Middle East and North Africa
3
Russia
3
Yemen
3
Ukraine
1
Global
1
Latin America and the Carribbean
1
Sudan
1
South Sudan
1
Authors & Publishers
World Health Organization WHO
17
World Health Organization (WHO)
6
World Health Organization
4
UNITAID
3
Balamurali, M.
1
Berger, S.
1
BioNTech
1
Brindha, J.
1
Brot für die Welt
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
Centers for Disease Control and Prevention CDC
1
European Medicines Agency EMA
1
European Society of Clinical Microbiology and Infectious Diseases EUCAST
1
Food and Agriculture Organization (FAO)
1
Frontiers in Chemistry
1
Gideon
1
Greinacher, A., et al.
1
HIV i-Base
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
Kang Yiu Lai, Wing Yiu George Ng and Fan Fanny Cheng
1
Kaushik, C.
1
Logunov, D.Y, et al.
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
P. Clayden
1
Pfizer
1
Polack, F.P. et al.
1
UN Environment
1
UN United Nations
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
Countries
7
Clinical Guidelines
3
Pharmacy & Technologies
2
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
22
Ebola
6
Planetary Health
6
Pharmacy
3
Global Health Education
3
Rapid Response
2
AMR
2
HIV
1
TB
1
NTDs
1
Conflict
1
Zika
1
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health. The Nanomaterials chapter talks about this relatively new technology and its potential impacts on the environment a... more
July 2021
9 Febr. 2022 The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
10 December 2020
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
15 Dec 2021
New England Journal of Medicine April 9, 2021 DOI: 10.1056/NEJMoa2104840
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level. The aim of the document is to assist Member States and releva... more
3 March 2016
This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ... more

Malaria diagnostics technology and market landscape. 3rd edition

UNITAID World Health Organization (WHO) (2016) C_WHO
HIV i-Base July 2018
A role for nuclear techniques Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic... more
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical... more
interim guidance, 23 December 2020